IDEXX Laboratories Non-GAAP EPS of $2.07 beats by $0.15, revenue of $828.57M beats by $7.66M, initiates 2023 guidance
IDEXX Laboratories press release  (NASDAQ:IDXX): Q4  Non-GAAP EPS of $2.07  beats by $0.15.
Revenue of $828.57M (+3.4% Y/Y)  beats by $7.66M.
FY2023 Outlook: Revenue of $3.595B to $3.69BÂ  and consensus of $3.62B;Â Â operating margins of 29% to 29.6%; EPS outlook of $9.27 to $9.75 vs. consensus of $9.51.